Covering current events in science, the environment, technology and health requires a context and reliable sources that respond quickly.

¿Qué me ofrece?

When science hits the headlines, we publish reactions, explanations, and in-depth analysis from reliable sources, capturing both the evidence and the debates. Our library of science journalism resources and the upcoming briefings may be of use to you. Consult our directory of research centres.

Cómo trabajamos

We are on the lookout for any controversial information about science (embargoed or not), in order to react with the agility the media needs. Sign up to access our embargoed contents, all under the Creative Commons licence. Find out more about how we work here.

Título qué me ofrece
What we offer you
Título cómo trabajamos
How we work

Reactions to Nobel Prize in Chemistry for Bertozzi, Meldal and Sharpless for click chemistry and its use in living organisms

The Nobel Prize in Chemistry 2022 has been awarded to Barry Sharpless and Morten Meldal for laying the foundations of click chemistry, which quickly and efficiently joins molecular building blocks; and to Carolyn Bertozzi, who pioneered bioorthogonal reactions, which use this technique inside living organisms without altering the chemistry of the cell.


Reactions to Nobel Prize in Physics for Aspect, Clauser and Zeilinger for pioneering quantum information

The Royal Swedish Academy of Sciences has awarded the Nobel Prize in Physics to Alain Aspect, John F. Clauser and Anton Zeilinger for their experiments with entangled photons, establishing the violation of Bell's inequalities and becoming pioneers in quantum information science.


What we know about the first case of H5N1 avian influenza in humans detected in Spain

The National Microbiology Centre has confirmed the first positive human case of H5N1 avian influenza detected in Spain, Animal's Health said yesterday. This is the worker of a poultry farm located in the province of Guadalajara who remained asymptomatic and isolated until he tested negative. This is the second case detected in Europe after the UK declared its case in January this year.


Reactions: EMA recommends that codeine-ibuprofen combination medicines warn of possible serious harm

The European Medicines Agency (EMA) safety committee (PRAC) has recommended a change to the information on codeine-ibuprofen combination medicines to include "a warning about serious harm, including death, especially when taken for prolonged periods at higher than recommended doses". The PRAC reviewed several cases of renal, gastrointestinal and metabolic toxicity that had been reported in association with cases of abuse and dependence on these drugs.